| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.10B | $919.1M | $855.8M |
| YoY Revenue Growth % | +19.2% | +7.4% | — |
| Gross Profit | $461.1M | $388.6M | — |
| Gross Margin % | 42.1% | 42.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $170.4M | $146.2M | $119.1M |
| Operating Margin % | 15.6% | 15.9% | 13.9% |
| Net Income (GAAP) | $299.2M | $101.9M | $92.5M |
| EBITDA (Normalized) | $209.8M | $179.3M | $149.9M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $241.9M | $127.5M | $76.9M |
| Capital Expenditures (CapEx) | $49.3M | $41.4M | $38.5M |
| Free Cash Flow (FCF) | $192.6M | $86.2M | $38.4M |
| FCF Margin % | 17.6% | 9.4% | 4.5% |
| Return on Invested Capital (ROIC %) | 8.5% | 9.2% | 3.7% |
| Cash & Short-Term Equivalents | $103.8M | $71.3M | — |
| Total Debt (Short + Long Term) | $125.0M | $92.0M | $977.3M |
| Total Stockholders' Equity | $1.56B | $1.24B | $2.00B |